[Clinical value of OK-432 immunotherapy after one-shot arterial infusion of anti-cancer agents in the treatment of hepatocellular carcinoma--a randomized study].
作者信息
Horie Y, Hirai K, Shimizu M, Inoue J, Kubo Y, Hara Y, Tanikawa K, Okumura M, Hirayama C, Ogawa N
机构信息
2nd Dept. of Medicine, Tottori University School of Medicine.